Kelly Stolzmann

Kelly Stolzmann

Auto-generated profile, based on publicly available information

Kelly Stolzmann

VA Boston Healthcare System

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in American Psychologist
Verified
Journal Article
Closed access
SCSamantha L. Connolly
Samantha L. Connolly
KSKelly L. Stolzmann
Kelly L. Stolzmann
LHLeonie Heyworth
Leonie Heyworth
JSJennifer Sullivan
Jennifer Sullivan
SSStephanie L. Shimada
Stephanie L. Shimada
CMChristopher J. Miller
Christopher J. Miller
The current study examined patient and provider differences in use of phone, video, and in-person mental health (MH) services. Participants included patients who completed ≥1 MH appointment within the Department of Veterans Affairs (VA) from 10/1/17-7/10/20 and providers who completed ≥100 VA MH appointments from 10/1/17-7/10/20. Adjusted odds ratios (aORs) are reported of patients and providers: 1) completing ≥1 video MH appointment in the pre-COVID (10/1/17-3/10/20) and COVID (3/11/20-7/10/20) periods; and 2) completing the majority of MH visits via phone, video, or in-person during COVID. The sample included 2,480,119 patients/31,971 providers in the pre-COVID period, and 1,054,670 patients/23,712 providers in the COVID period. During the pre-COVID and COVID periods, older patients had lower odds of completing ≥1 video visit (aORs <0.65). During the COVID period, older age and low socioeconomic status predicted lower odds of having ≥50% of visits via video versus in-person or phone (aORs <0.68); schizophrenia and MH hospitalization history predicted lower odds of having ≥50% of visits via video or phone versus in-person (aORs <.64). During the pre-COVID and COVID periods, non-psychologists (e.g., psychiatrists) had lower odds of completing video visits (aORs <0.44). Older providers had lower odds of completing ≥50% of visits via video during COVID (aORs <.69). Findings demonstrate a digital divide, such that older and lower income patients, and older providers, engaged in less video care. Non-psychologists also had lower video use. Barriers to use must be identified and strategies must be implemented to ensure equitable access to video MH services.

1 December 2015 in Implementation Science
Verified
Journal Article
Open access
PDF file
MBMark S. Bauer
Mark S. Bauer
CMChristopher Miller
Christopher Miller
BKBo Kim
Bo Kim
RLRobert Lew
Robert Lew
KWKendra Weaver
Kendra Weaver
JKJoAnn Kirchner
JoAnn Kirchner
Outcome for mental health conditions is suboptimal, and care is fragmented. Evidence from controlled trials indicates that collaborative chronic care models (CCMs) can improve outcomes in a broad array of mental health conditions. US Department of Veterans Affairs leadership launched a nationwide initiative to establish multidisciplinary teams in general mental health clinics in all medical centers. As part of this effort, leadership partnered with implementation researchers to develop a program evaluation protocol to provide rigorous scientific data to address two implementation questions: (1) Can evidence-based CCMs be successfully implemented using existing staff in general mental health clinics supported by internal and external implementation facilitation? (2) What is the impact of CCM implementation efforts on patient health status and perceptions of care? Health system operation leaders and researchers partnered in an iterative process to design a protocol that balances operational priorities, scientific rigor, and feasibility. Joint design decisions addressed identification of study sites, patient population of interest, intervention design, and outcome assessment and analysis. Nine sites have been enrolled in the intervention-implementation hybrid type III stepped-wedge design. Using balanced randomization, sites have been assigned to receive implementation support in one of three waves beginning at 4-month intervals, with support lasting 12 months. Implementation support consists of US Center for Disease Control’s Replicating Effective Programs strategy supplemented by external and internal implementation facilitation support and is compared to dissemination of materials plus technical assistance conference calls. Formative evaluation focuses on the recipients, context, innovation, and facilitation process. Summative evaluation combines quantitative and qualitative outcomes. Quantitative CCM fidelity measures (at the site level) plus health outcome measures (at the patient level; n = 765) are collected in a repeated measures design and analyzed with general linear modeling. Qualitative data from provider interviews at baseline and 1 year elaborate CCM fidelity data and provide insights into barriers and facilitators of implementation. Conducting a jointly designed, highly controlled protocol in the context of health system operational priorities increases the likelihood that time-sensitive questions of operational importance will be answered rigorously and that the outcomes will result in sustainable change in the health-care system. NCT02543840 ( https://www.clinicaltrials.gov/ct2/show/NCT02543840 ).

31 May 2009 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
PDF file
LMLeslie R. Morse
Leslie R. Morse
ALAntonio A. Lazzari
Antonio A. Lazzari
RBRicardo Battaglino
Ricardo Battaglino
KSKelly L. Stolzmann
Kelly L. Stolzmann
KMKirby R. Matthess
Kirby R. Matthess
EGEric Garshick
Eric Garshick

28 June 2017 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ALAmy Linsky
Amy Linsky
MMMark Meterko
Mark Meterko
KSKelly Stolzmann
Kelly Stolzmann
SSSteven R. Simon
Steven R. Simon
One approach to prevent adverse drug events is to discontinue (“deprescribe”) medications that are outdated, not indicated, or of limited benefit relative to risk for a particular patient. However, there is little guidance to clinicians about how to integrate the process of deprescribing into the workflow of clinical practice. We sought to determine clinical prescribers’ preferences for interventions that would improve their ability to appropriately and proactively discontinue medications. We conducted a national web-based survey of 2475 prescribers [physicians, nurse practitioners (NP), physician assistants (PA), and clinical pharmacy specialists] practicing in US Veterans Affairs (VA) primary care clinics. One survey question presented 15 potential changes to medication-related practices and respondents ranked their top three choices for changes that would “most improve [their] ability to discontinue medications.” We summed the weighted rankings for each of the 15 response options. Preferences were determined for the whole sample and within subgroups of respondents defined by demographic and background characteristics, medication-relevant experience, and beliefs. Among the 326 respondents who provided rankings, the top choice for a change that would help improve their ability to discontinue medications was “Requiring all medication prescriptions to have an associated ‘indication for use.’” This preference was followed by “Assistance with follow-up of patients as they taper or discontinue medications is performed by another member of the Patient Aligned Care Team (PACT)” and “Increased patient involvement in prescribing decisions.” This combination of options, albeit in varying rank order, was the most commonly selected, with 250 respondents (77%) who answered the question including at least one of these items in their three highest ranked choices, regardless of their demographics, experience, or beliefs. Continued efforts to improve clinicians’ ability to make prescribing decisions, especially around deprescribing, have many potential benefits, including decreased pharmaceutical and health care costs, fewer adverse drug events and complications, and improved patient involvement and satisfaction with their care. Future work, whether as research or quality improvement, should incorporate clinicians’ preferences for interventions, as greater buy-in from front-line staff leads to better adoption of changes.

7 April 2023 in American Journal of Preventive Medicine
Verified
Journal Article
Open access
KIKatherine M Iverson
Katherine M Iverson
KSKelly L. Stolzmann
Kelly L. Stolzmann
JBJulianne E. Brady
Julianne E. Brady
OAOmonyêlé L. Adjognon
Omonyêlé L. Adjognon
MDMelissa E. Dichter
Melissa E. Dichter
CMChristopher J. Miller
Christopher J. Miller
The Veterans Health Administration initiated implementation facilitation to integrate intimate partner screening programs in primary care. This study investigates implementation facilitation's impact on implementation and clinical effectiveness outcomes. A cluster randomized, stepped-wedge, hybrid-II implementation-effectiveness trial (January 2021-April 2022) was conducted amidst the COVID-19 pandemic. Implementation facilitation was applied at 9 Veterans Health Administration facilities, staged across 2 waves. Participants were all women receiving care at participating primary care clinics 3 months before (pre-implementation facilitation n=2,272) and 9 months after initiation of implementation facilitation (implementation facilitation n=5,149). Implementation facilitation included an operations-funded external facilitator working for 6 months with a facility-funded internal facilitator from participating clinics. The pre-implementation facilitation period comprised implementation as usual in the Veterans Health Administration. Primary outcomes were changes in (1) reach of intimate partner violence (IPV) screening programs among eligible women (i.e., those seen within participating clinics during the assessment period; implementation outcome) and (2) disclosure rates among screened women (effectiveness outcome). Secondary outcomes included disclosure rates among all eligible women and post-screening psychosocial service use. Administrative data were analyzed. For primary outcomes, women seen during the implementation facilitation period were nearly 3 times more likely to be screened for IPV than women seen during the pre-implementation facilitation period (OR=2.70, 95% CI=2.46, 2.97). Women screened during the implementation facilitation period were not more likely to disclose IPV than those screened during the pre-implementation facilitation period (OR=1.14, 95% CI=0.86, 1.51). For secondary outcomes, owing to increased reach of screening during implementation facilitation, women seen during the implementation facilitation period were more likely to disclose IPV than those seen during the pre-implementation facilitation period (OR=2.09, 95% CI=1.52, 2.86). Women screened during implementation facilitation were more likely to use post-screening psychosocial services than those screened during pre-implementation facilitation (OR=1.29, 95% CI=1.06, 1.57). Findings indicate that implementation facilitation may be a promising strategy for increasing the reach of IPV screening programs in primary care, thereby increasing IPV detection and strengthening connections to support services among the patient population. This study is registered at www. gov NCT04106193.

3 May 2019 in Implementation Science
Verified
Journal Article
Open access
PDF file
RLRobert A. Lew
Robert A. Lew
CMChristopher J. Miller
Christopher J. Miller
BKBo Kim
Bo Kim
HWHongsheng Wu
Hongsheng Wu
KSKelly Stolzmann
Kelly Stolzmann
MBMark S. Bauer
Mark S. Bauer
Controlled implementation trials often randomize the intervention at the site level, enrolling relatively few sites (e.g., 6–20) compared to trials that randomize by subject. Trials with few sites carry a substantial risk of an imbalance between intervened (cases) and non-intervened (control) sites in important site characteristics, thereby threatening the internal validity of the primary comparison. A stepped wedge design (SWD) staggers the intervention at sites over a sequence of times or time waves until all sites eventually receive the intervention. We propose a new randomization method, sequential balance, to control time trend in site allocation by minimizing sequential imbalance across multiple characteristics. We illustrate the new method by applying it to a SWD implementation trial. The trial investigated the impact of blended internal-external facilitation on the establishment of evidence-based teams in general mental health clinics in nine US Department of Veterans Affairs medical centers. Prior to randomization to start time, an expert panel of implementation researchers and health system program leaders identified by consensus a series of eight facility-level characteristics judged relevant to the success of implementation. We characterized each of the nine sites according to these consensus features. Using a weighted sum of these characteristics, we calculated imbalance scores for each of 1680 possible site assignments to identify the most sequentially balanced assignment schemes. From 1680 possible site assignments, we identified 34 assignments with minimal imbalance scores, and then randomly selected one assignment by which to randomize start time. Initially, the mean imbalance score was 3.10, but restricted to the 34 assignments, it declined to 0.99. Sequential balancing of site characteristics across groups of sites in the time waves of a SWD strengthens the internal validity of study conclusions by minimizing potential confounding. Registered at ClinicalTrials.gov as clinical trials # NCT02543840 ; entered 9/4/2015.